Results 221 to 230 of about 1,917,601 (292)

Low Allergic Sensitisation in Wheezing Children With Down Syndrome: A Case–Control Study

open access: yesJournal of Intellectual Disability Research, EarlyView.
ABSTRACT Background Respiratory disorders are frequent in children with Down syndrome (DS), causing prolonged hospitalisations and increased healthcare system costs. Among these, recurrent wheezing is common in these children despite indications of lower rates of allergic sensitisation and asthma.
Francylene Malheiros Macedo da Cunha Rego   +6 more
wiley   +1 more source

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation.

open access: yesInt Arch Allergy Immunol
Özden Ş   +8 more
europepmc   +1 more source

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2. [PDF]

open access: yesClin Exp Allergy
Penz E   +12 more
europepmc   +1 more source

Eczema and Lung Function Across the Life Course: A Systematic Review

open access: yes
Clinical &Experimental Allergy, EarlyView.
Mohammed K. Alghasham   +8 more
wiley   +1 more source

Oral Health, Periodontitis, and Respiratory Diseases: Biological Pathways

open access: yesJournal of Periodontal Research, EarlyView.
This narrative review aims to provide a comprehensive update on the potential mechanisms by which poor oral health and periodontitis impact lung health, focusing on pneumonia, COPD, and asthma. ABSTRACT Poor oral hygiene and periodontitis influence lung diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), COVID‐19, and asthma.
Raluca P. Vacaru   +2 more
wiley   +1 more source

Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment. [PDF]

open access: yesInt J Mol Sci
Niemiec-Górska A   +8 more
europepmc   +1 more source

Benralizumab Inhibits Upper Airway Expression of Thymic Stromal Lymphopoietin in Severe Asthma

open access: yes
Clinical &Experimental Allergy, EarlyView.
Hazel Marriott   +5 more
wiley   +1 more source

Growth Assessment in Children Under 12 Years With Moderate‐to‐Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Background/Objective The multifactorial disease burden of moderate‐to‐severe atopic dermatitis (AD) may affect children's growth. We report height, weight, and body mass index (BMI) of children under 12 years old with moderate‐to‐severe AD in comparison to the general population.
Amy S. Paller   +11 more
wiley   +1 more source

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma. [PDF]

open access: yesERJ Open Res
Pham DD   +28 more
europepmc   +1 more source

Treatment of Canine Atopic Dermatitis: Updated Guidelines From the International Committee on Allergic Diseases of Animals (ICADA)

open access: yesVeterinary Dermatology, EarlyView.
ABSTRACT Background Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous ...
Ralf S. Mueller   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy